Salvage Therapy with Cladribine for Refractory and Relapsed Pediatric Langerhans Cell Histiocytosis: An Update Nationwide Survey in Japan

被引：0
|
作者：
Taniguchi, Maki [1 ]
Sakamoto, Kenichi [2 ]
Doi, Takehiko [3 ]
Kudo, Ko [4 ]
Fujino, Hisanori [5 ]
Shioda, Yoko [2 ]
Kudo, Kazuko [6 ]
Morimoto, Akira [7 ]
机构：
[1] JA Onomichi Gen Hosp, Dept Pediat, Onomichi, Japan
[2] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan
[3] Hiroshima Univ Hosp, Dept Pediat, Hiroshima, Japan
[4] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan
[5] Osaka Red Cross Hosp, Dept Pediat, Osaka, Japan
[6] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan
[7] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS16-1-3
引用
收藏
页数：2
相关论文
共 50 条
  • [31] EVALUATING ANTI-TNF-ALPHA THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY LANGERHANS CELL HISTIOCYTOSIS
    Burke, Thomas
    Legarreta, Alejandra
    Lin, Howard
    Scull, Brooks
    Eckstein, Olive
    McClain, Kenneth
    Allen, Carl
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S2 - S3
  • [32] Evaluating Anti-TNF-Alpha Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis
    Burke, Thomas
    Legarreta, Alejandra
    Lin, Howard
    Scull, Brooks
    Eckstein, Olive S.
    McClain, Kenneth L.
    Allen, Carl E.
    [J]. BLOOD, 2018, 132
  • [33] Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis: A Single Centre Experience
    Dua, Vikas
    Yadav, Satya Prakash
    Sachdeva, Anupam
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2014, 81 (03): : 315 - 316
  • [34] Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis: A Single Centre Experience
    Vikas Dua
    Satya Prakash Yadav
    Anupam Sachdeva
    [J]. The Indian Journal of Pediatrics, 2014, 81 : 315 - 316
  • [35] CYCLOSPORINE THERAPY FOR REFRACTORY LANGERHANS CELL HISTIOCYTOSIS - RESPONSE
    MAHMOUD, H
    [J]. BLOOD, 1991, 78 (11) : 3107 - 3107
  • [36] Reduced Doses of Cladribine Plus Cytarabine for Refractory or Reactivated Langerhans Cell Histiocytosis (LCH)
    Gutierrez, M. F.
    Urbieta, M.
    Lombardi, M. Garcia
    Ramirez, R.
    Acosta, S.
    Oller, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S297 - S297
  • [37] Anti TNF- therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study
    Legarreta, Alejandra Flores
    Eckstein, Olive
    Burke, Thomas M.
    McClain, Kenneth L.
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2018, 35 (5-6) : 362 - 368
  • [38] NATIONWIDE SURVEY OF SINGLE SYSTEM SINGLE SITE (SS-S) LANGERHANS CELL HISTIOCYTOSIS IN JAPAN
    Morimoto, A.
    Ishii, E.
    Ohga, S.
    Kudou, K.
    Ishida, Y.
    Suzuki, N.
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (04) : 688 - 688
  • [39] Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
    Goyal, Gaurav
    Hu, Marie
    Abeykoon, Jithma P.
    Bennani, Nora N.
    Ryu, Jay H.
    Shah, Mithun Vinod
    Vassallo, Robert
    Go, Ronald S.
    [J]. BLOOD, 2019, 134
  • [40] Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas
    Naumann-Bartsch, Nora
    Stachel, Daniel
    Chada, Martin
    Fritscher, Torsten
    Rompel, Oliver
    Haller, Florian
    Hartmann, Arndt
    Wossmann, Wilhelm
    Metzler, Markus
    [J]. BLOOD, 2016, 128 (22)
12345